Chronic Delta Hepatitides refers to a group of liver diseases characterized by a persistent inflammation of the liver caused by the hepatitis delta virus (also known as hepatitis D virus or HDV). This condition is chronic in nature, meaning that it lasts for an extended period of time, typically more than six months.
Hepatitis delta virus is a small RNA virus that can only infect individuals who are already infected with the hepatitis B virus (HBV). The presence of HDV in combination with HBV can result in more severe liver damage compared to HBV infection alone.
The chronic delta hepatitides often present with similar symptoms to other forms of viral hepatitis, including fatigue, loss of appetite, jaundice, abdominal pain, and liver enlargement. Furthermore, individuals with chronic delta hepatitides are at an increased risk of developing cirrhosis, liver failure, and hepatocellular carcinoma (a type of liver cancer).
Treatment options for chronic delta hepatitides are limited and usually involve antiviral therapy with a combination of HBV and HDV medications. However, not all affected individuals respond well to treatment, and the outcome can vary depending on the severity of liver damage at the time of diagnosis.
In conclusion, chronic delta hepatitides are a group of liver diseases characterized by persistent inflammation of the liver caused by the hepatitis delta virus. It is associated with an increased risk of liver damage, cirrhosis, liver failure, and hepatocellular carcinoma.
